India’s pharmaceutical industry is facing potential tariffs imposed by President Trump, which could significantly impact exports, particularly to the US. High export dependence and questionable quality standards underscore the need for reform and improved regulation to maintain the industry’s reputation and market position.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8eUAmoG
via IFTTT
No comments:
Post a Comment